Re-expression of the embryonic stem cell and pluripotency factors OCT4, SOX2, and NANOG has been associated with poorly differentiated and aggressive cancers, such as high-grade breast cancer, glioblastomas, and bladder carcinomas [29]. This evidence concerns the gene SOX2 and urinary bladder carcinoma.